Upcoming Webinars
-
Wearable and Home-use Devices Part 2: FDA Submissions
In this webinar, Tyler Ting, Director of Regulatory at Rook Quality Systems, walks you through the FDA submission landscape specific to wearable and home-use devices, so you can move from development to clearance with confidence.
Register for Wearable and Home-use Devices Part 2: FDA Submissions Read More about Wearable and Home-use Devices Part 2: FDA Submissions
Past Webinars
-
FDA Regulation of AI in Life Sciences Webinar | Medmarc
Join us to learn about strategies for approaching FDA with your AI products. Nathan Downing of Gardner Law will discuss pre-market activities, submission strategies, and post-market considerations to make your regulatory strategy a success.
Read More about FDA Regulation of AI -
Introduction to Human Factors Engineering
Join Emergo by UL’s Human Factors Research & Design team to learn about the regulatory imperatives – and commercial benefits – associated with applying Human Factors Engineering (HFE) throughout medical device development.
Read More about Introduction to Human Factors Engineering – The Key to Developing Safe, Effective, and Usable Medical Devices -
Sales Representative in the OR: Navigating a Liability Minefield for a 15-year Retrospective
15 years ago, Medmarc launched its very first Risk Management Webinar with presenter Eric Zalud on the topic of Sales Representatives in the OR: Navigating a Liability Minefield. For our 45th anniversary celebration we have invited back Eric to revisit this topic for a 15-year retrospective.
Read More about Sales Representative in the OR: Navigating a Liability Minefield a 15-year Retrospective -
Important Export Control Considerations for the Life Sciences Industry
Join us to learn about the nuts and bolts of export controls - including potential regulatory restrictions - confronting manufacturers and distributors of medical devices, pharmaceuticals, and other technologies who sell their products to foreign buyers.
Read More about Important Export Control Considerations for the Life Sciences Industry